Light Mode
$118.51 ↑ +0.00 (+0.00%) Trading Up from the previous close of $118.51, $0.69 below the day’s high of $119.20
+58.03 (+95.95%) / 6M
Momentum, market sentiment, and recent alerts
HAE reads very good: price sits above both the 20- and 200-day averages, short interest is rising month over month, the 12-month move is +131.4%.
No alerts for HAE in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
